The estimated Net Worth of Robert Harry Beechey is at least $1.34 Milión dollars as of 15 November 2019. Mr. Beechey owns over 5,000 units of Vermillion stock worth over $840,000 and over the last 7 years he sold VRML stock worth over $0. In addition, he makes $501,532 as Chief Financial Officer at Vermillion.
Sign up
Mr. Beechey VRML stock SEC Form 4 insiders trading
Robert has made over 5 trades of the Vermillion stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VRML stock worth $3,550 on 15 November 2019.
The largest trade he's ever made was buying 100,000 units of Vermillion stock on 14 August 2018 worth over $52,000. On average, Robert trades about 21,000 units every 46 days since 2017. As of 15 November 2019 he still owns at least 210,000 units of Vermillion stock.
You can see the complete history of Mr. Beechey stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Beechey biography
Robert Harry Beechey has been appointed as Chief Financial Officer of the Company. Effective December 18 2017., Robert Beechey joined Vermillion in December 2017 as our Chief Financial Officer. Prior to joining the Company, Mr. Beechey spent three years with Q2 Solutions, a Quintiles Quest joint venture that provides clinical trial laboratory services. From 2016 to 2017, he served as Vice President and General Manager and, from 2015 to 2016, he served as Chief Financial Officer. From 2011 to 2015, Mr. Beechey served as Vice President of Quintiles Transnational Corporation, a research, clinical trial and pharmaceutical consulting services company that was acquired by Quintiles IMS Inc. in 2016. He also spent four years with Thermo Fisher Scientific and over ten years with Eastman Kodak Company. Mr. Beechey received his Bachelors of Science in Economics from the Wharton School of the University of Pennsylvania, and his M.B.A. from Insead.
What is the salary of Robert Beechey?
As the Chief Financial Officer of Vermillion, the total compensation of Robert Beechey at Vermillion is $501,532. There are 1 executives at Vermillion getting paid more, with Valerie Palmieri having the highest compensation of $941,832.
How old is Robert Beechey?
Robert Beechey is 57, he's been the Chief Financial Officer of Vermillion since 2017. There are 6 older and no younger executives at Vermillion. The oldest executive at Vermillion, Inc. is James Burns, 73, who is the Independent Director.
What's Robert Beechey's mailing address?
Robert's mailing address filed with the SEC is 12117 Bee Caves Rd BLDG 3 STE 100, Bee Cave, TX 78738, USA.
Insiders trading at Vermillion
Over the last 17 years, insiders at Vermillion have traded over $1,008,376 worth of Vermillion stock and bought 29,557,130 units worth $34,088,488 . The most active insiders traders include Jack W Schuler, Henri George Schuler a Larry Noracle Partners Lp F.... On average, Vermillion executives and independent directors trade stock every 59 days with the average trade being worth of $1,572,028. The most recent stock trade was executed by Robert Harry Beechey on 15 November 2019, trading 5,000 units of VRML stock currently worth $3,550.
What does Vermillion do?
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
What does Vermillion's logo look like?
Complete history of Mr. Beechey stock trades at Vermillion
Vermillion executives and stock owners
Vermillion executives and other stock owners filed with the SEC include:
-
Valerie Palmieri,
President, Chief Executive Officer, Director -
Robert Beechey,
Chief Financial Officer -
Nancy Cocozza,
Independent Director -
James LaFrance,
Independent Chairman of the Board -
Veronica Jordan,
Independent Director -
David Schreiber,
Independent Director -
James Burns,
Independent Director -
Sandra Brooks,
Independent Director -
Jack W Schuler,
-
Peter S Roddy,
Director -
Carl Severinghaus,
Director -
Larry Noracle Partners Lp O...,
-
Donald G Munroe,
SVP Business Development & CSO -
Henri George Schuler,
10% owner -
Holly B Bauzon,
VP Managed Markets -
Fred Ferrara,
Chief Information Officer -
Rajen Dalal,
Director -
Gail S Page,
President and CEO -
Qun Zhou,
Interim CFO -
Laura Ann Miller,
SVP Sales & Cust Experience -
Robert St Leger Goggin,
Director -
Ashish Kohli,
VP of Corporate Strategy -
Michael J Callaghan,
Director -
Marian E Sacco,
See Remarks -
Thomas H Mclain,
CEO & President -
James L Rathmann,
Director -
Eric Varma,
Director -
Larry Noracle Partners Lp O...,
-
John F Hamilton,
Director -
William C Wallen,
Director -
Bruce A Huebner,
Director -
William B. Creech,
VP Sales and Marketing -
Eric Schoen,
VP Finance & CAO -
Eric T Fung,
VP-Chief Science Officer -
Sandra A. Gardiner,
VP & Chief Financial Officer -
Judy Bruner,
Director -
Partners L Pwiggins James P...,
-
Diagnostics Inc Quest,
10% owner -
Kenneth J Conway,
Director -
Simon C. Shorter,
VP, Corp Business Development -
John A Young,
Director -
Larry Noracle Partners Lp F...,